Nabumetone
- Product NDC
- 55289-609
- 11-digit product format
- 552890609
- Labeler code
- 55289
- Product ID
- 55289-609_d2917d99-fd50-8e0f-e053-2a95a90ae747
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumentone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA075280
- Marketing category
- ANDA
- Marketing start
- 2002-02-25
- Marketing end
- 2022-07-31
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55289-609-20 | 55289060920 | 20 TABLET in 1 BOTTLE, PLASTIC (55289-609-20) | 20 tablet | 2011-09-26 | 2022-07-31 | No | No | Current |
| 55289-609-30 | 55289060930 | 30 TABLET in 1 BOTTLE, PLASTIC (55289-609-30) | 30 tablet | 2011-09-26 | 2022-07-31 | No | No | Current |
| 55289-609-40 | 55289060940 | 40 TABLET in 1 BOTTLE, PLASTIC (55289-609-40) | 40 tablet | 2011-09-26 | 2022-07-31 | No | No | Current |
| 55289-609-60 | 55289060960 | 60 TABLET in 1 BOTTLE, PLASTIC (55289-609-60) | 60 tablet | 2011-09-26 | 2022-07-31 | No | No | Current |